Biocon Limited is engaged in the manufacture of biotechnology products and research services. The Company is a public limited company incorporated and domiciled in India. The Company’s shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India.

Business area of the company

The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development. 

Biocon Ltd.

Lupin Ltd.

Alkem Laboratories Ltd.

Gland Pharma Ltd.

Aurobindo Pharma Ltd.

Zydus Lifesciences Ltd.

Abbott India Ltd.

Laurus Labs Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Ipca Laboratories Ltd.

Pfizer Ltd.

Piramal Enterprises Ltd.

Ajanta Pharma Ltd.

JB Chemicals & Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	34,061 Cr		EPS	8.9		High	285.55
Stock P/E	32.0		Net Profit Margin	4.7		Low	282

Open Price	283.55	Volume	1,258
Prev. Close	283.55

BIOCON